Invus is a global investment firm that specializes in partnering with exceptional entrepreneurs and management teams to help build companies with enduring value. They focus on making long-term investments and providing strategic, operational, and financial support to their portfolio companies.

Evergreen structure with over $8 billion under management. Offices in New York, Paris, Singapore, and Hong Kong.

Cyclerion Therapeutics

EQRx

Erasca

Standard BioTools

Moderna

Abivax

Ambrx

Fusion Pharmaceuticals

BioNTech

Black Diamond Therapeutics

Arcus Biosciences

Morphic Therapeutic

Immunic Therapeutics

ORIC Pharmaceuticals

Oyster Point Pharmaceuticals

Cerevel Therapeutics

Schrödinger

Seer

Senti Biosciences

PatientsLikeMe

Solid Biosciences

SQZ Biotech

Taysha Gene Therapies

Thrive Earlier Detection

TigerConnect

UNITY Biotechnology

Vigil Neuroscience

The Invus Group

Invus

COM:INVUS

Invus

Analysis Not Available